Corporate and Individual Behavior
July 12, 2009 by admin · Leave a Comment
After this long and hopefully provocative introduction to the conflicts between economic efficiency and ethical considerations, this blog now offers thirty questions that have both ethical and economic consequences. Do not expect these questions to have clear answers. You may even find some of the expositions or scenarios to be not only controversial but outright offensive. Perhaps this is unavoidable to get you to consider ethics not just as “yet-another-exercise necessary to pass a class,” but as “food for thought.” To learn, it is essential that you discuss ethical dilemmas with your colleagues and friends. I promise that you will not only find the discussion entertaining, but that you will be shocked as to how widely differing their points of views will be.
For all of the scenarios that follow, it is important that you consider whether your answers depend on the following:
• if you have exclusive access to the economic resource in question. For example, are you the only producer of your product or the only available employer, or are there many standby alternatives?
• if the fact that others (e.g., your competitors) engage in the same questionable activity can excuse or mitigate your own ethical flaws.
• if you represent yourself or if you represent someone else—that is, if you are the sole owner of the company vs. if you are a part owner of the company vs. if you are an executive of a company.
Who you represent is an important “if.” By law, as a corporate executive, you have a fiduciary obligation to your shareholders. The seminal opinion on this subject was written by the New York Court of Appeals in 1984:
Because the power to manage the affairs of a corporation is vested in the directors and majority shareholders, they are cast in the fiduciary role of “guardians of the corporate welfare.” In this position of trust, they have an obligation to all shareholders to adhere to fiduciary standards of conduct and to exercise their responsibilities in good faith when undertaking any corporate action. Actions that may accord with statutory requirements are still subject to the limitation that such conduct may not be for the aggrandizement or undue advantage of the fiduciary to the exclusion or detriment of the stockholders.
The fiduciary must treat all shareholders, majority and minority, fairly. Moreover, all corporate responsibilities must be discharged in good faith and with “conscientious fairness, morality and honesty in purpose.” Also imposed are the obligations of candor and of good and prudent management of the corporation. When a breach of fiduciary duty occurs, that action will be considered unlawful and the aggrieved shareholder may be entitled to equitable relief.
Most economists and a number of courts have interpreted fiduciary responsibility to mean that managers must maximize shareholders’ profits to the best of their abilities.
• if you do not represent the corporate entity, but the government. That is, would you argue in favor of an action if you were a corporation that you would prohibit if you were the government? If you do take the stance that it is the role of the government to make rules and companies should be free to live inside the rules, then also consider also that companies are free to donate to politicians and lobby government—and many actively do so to influence governmental rules and legislation. Is the government a benevolent arbitrator, or a set of politicians willing to be corrupted?
• if the social cost to prevent an unethical behavior is too high. In some instances, it might require an Orwellian police state to prevent a non-desirable behavior. In other cases, “paying to prevent bad behavior” may also create bad incentives for future bad behavior that tries to obtain such payments in the first place.
• if you do not represent either the corporation or the government, but your faith’s religious institution. How do you reconcile your economic views with your religion’s ethical views?
Another interesting question is whether you consider the ethical dilemma to be rare or common, and whether you believe it to become more or less common in the future.
Each of the scenarios below is followed by some additional questions, often more specific than the above considerations. These additional questions are not replacements for the above set of questions.
You cannot possibly cover all 30 questions in an introductory finance course. In fact, you may not be able to discuss more than one or two points per class session. Given time constraints, to help you make a choice among the questions, I have marked some of the more important cases in bold and with an extra bullet.
An Insider Trading Case With Twists and Turns
July 12, 2009 by admin · Leave a Comment
Let us dive into a case in which all sorts of interesting economic and ethical issues arise. On Christmas 2002, Sam Waksal, CEO of ImClone, learned about negative interim F.D.A. test results on ImClone’s promising cancer drug Erbitux. He promptly informed his family before the test results became public knowledge, who sold their shares and thereby avoided millions of dollars of losses. In 2003, Waksal was indicted and sentenced to 7 years in jail for insider trading. (Ironically, the interim results only caused a delay. Waksal’s Erbitux seems to work and will probably save thousands of lives.)
Economists are divided on whether insider trading should be prohibited. First, informed trading aids market efficiency: it moves stock prices more quickly towards their correct values. Second, the zone between what constitutes illegal trading based on inside information vs. legal trading based on superior business knowledge can be rather gray. Third, the social cost of making sure that inside information neither leaks nor is exploited is very high, and we currently criminalize even many innocent slips.
But ignore for a moment whether insider trading should be legal or illegal. What is the right penalty for this currently illegal activity? Sam Waksal is one of the world’s top biotech experts. Some patients consider him a saint, though perhaps one with mild flaws, because his work has saved the lives of thousands of people. His incarceration will slow down the ongoing work of ImClone—a fact that could cost the lives of thousands more people who will no longer be able to benefit from what Waksal might yet have done. (What if Waksal’s efforts had saved or could save you or a family member?) Is it better to allow Waksal to forfeit a part of his fortune and thereby stay out of jail? The victims of his insider trading (the shareholders who bought the shares at too high a price) could be made better off. Cancer patients could be made better off. And Waksal would be made better off.
But there are problems with the financial penalty suggestion: If forfeiture became the sole legal remedy, would this be enough to deter future offenders? Could future insider traders avoid penalties if they sheltered their fortunes in shell companies? Would companies just make up the penalty for executives convicted of insider-trading?
More generally, should richer people, or people who have contributed more to society, or people who would contribute more to society (an economic gain that incarceration would destroy), be allowed to pay in order to get away with actions that others cannot get away with? We already can see some of this differentiation today: bail is more easily met by wealthier people, and many penalties come in the form of a choice to the offender: pay X dollars or go to jail. So, should we go so far as to allow richer people to commit crimes if this “can make everyone better off,” e.g., if we then had them pay ample compensation to the victims? What if they commit parking violations? breach of contract? speeding? fraud? rape? second-degree murder? first-degree murder? Where do we draw the line? (Consider that the victims could receive a lot of money that they might not otherwise receive. And consider that you could be the victim!)